Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation
Autor: | Siyu Deng, Diana C. Fasanello, Jin Su, Heather Freer, Elaheh Rahbar, Adam R. Hall, Matthew J. Paszek, Rose Yin, Felipe Rivas, Alicia Rollins, Carolyn M. Kelly, Heidi L. Reesink, Bettina Wagner, Joshua M. Berenson, Marshall J. Colville, Paul L. DeAngelis |
---|---|
Rok vydání: | 2021 |
Předmět: |
Diseases of the musculoskeletal system
Osteoarthritis chemistry.chemical_compound Chondrocytes Heavy chain-hyaluronic acid Hyaluronic acid Gene expression medicine Animals Synovial fluid Horses Hyaluronic Acid Microrheology TSG-6 Tumor Necrosis Factor-alpha Viscosity Cartilage Synovial membrane medicine.disease Molecular biology medicine.anatomical_structure SEC-MALS RC925-935 chemistry Agarose gel electrophoresis Research Article |
Zdroj: | Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-17 (2021) Arthritis Research & Therapy |
ISSN: | 1478-6362 |
DOI: | 10.1186/s13075-021-02588-7 |
Popis: | BackgroundTNF-α-stimulated gene 6 (TSG-6) protein, a TNF-α-responsive hyaladherin, possesses enzymatic activity that can catalyze covalent crosslinks of the polysaccharide hyaluronic acid (HA) to another protein to form heavy chain-hyaluronic acid (HC-HA) complexes in pathological conditions such as osteoarthritis (OA). Here, we examined HA synthase and inflammatory gene expression; synovial fluid HA, TNF-α, and viscosity; and TSG-6-mediated HC-HA complex formation in an equine OA model. The objectives of this study were to (1) evaluate the TNF-α-TSG-6-HC-HA signaling pathway across multiple joint tissues, including synovial membrane, cartilage, and synovial fluid, and (2) determine the impact of OA on synovial fluid composition and biophysical properties.MethodsHA and inflammatory cytokine concentrations (TNF-α, IL-1β, CCL2, 3, 5, and 11) were analyzed in synovial fluid from 63 OA and 25 control joints, and HA synthase (HAS1-3),TSG-6, and hyaluronan-degrading enzyme (HYAL2,HEXA) gene expression was measured in synovial membrane and cartilage. HA molecular weight (MW) distributions were determined using agarose gel electrophoresis and solid-state nanopore measurements, and HC-HA complex formation was detected via immunoblotting and immunofluorescence. SEC-MALS was used to evaluate TSG-6-mediated HA crosslinking, and synovial fluid and HA solution viscosities were analyzed using multiple particle-tracking microrheology and microfluidic measurements, respectively.ResultsTNF-α concentrations were greater in OA synovial fluid, andTSG6expression was upregulated in OA synovial membrane and cartilage. TSG-6-mediated HC-HA complex formation was greater in OA synovial fluid and tissues than controls, and HC-HA was localized to both synovial membrane and superficial zone chondrocytes in OA joints. SEC-MALS demonstrated macromolecular aggregation of low MW HA in the presence of TSG-6 and inter-α-inhibitor with concurrent increases in viscosity.ConclusionsSynovial fluid TNF-α concentrations, synovial membrane and cartilageTSG6gene expression, and HC-HA complex formation were increased in equine OA. Despite the ability of TSG-6 to induce macromolecular aggregation of low MW HA with resultant increases in the viscosity of low MW HA solutions in vitro, HA concentration was the primary determinant of synovial fluid viscosity rather than HA MW or HC-HA crosslinking. The TNF-α-TSG-6-HC-HA pathway may represent a potential therapeutic target in OA. |
Databáze: | OpenAIRE |
Externí odkaz: |